Gastrectomía total y esplenectomía por carcinoma gástrico proximal

Referencias bibliográficas:

1. Griffith JP, Sue-Ling HM, Martin I, et al Preservation of the spleen improves survival after radical surgery for gastric cancer. Gut 1995; 36:684–690.
2. Wanebo HJ, Kennedy BJ, Winchester DP, et al Role of splenectomy in gastric cancer surgery: adverse effect of elective splenectomy on long term survival. J Am Coll Surg 1997; 185:177–184.
3. Wang F, Chang YC, Chen TH, et al Prognostic significance of splenectomy for patients with gastric adenocarcinoma undergoing total gastrectomy: a retrospective cohort study. Int J Surg 2014; 12:557–565.
4. Csendes A, Burdiles P, Rojas J, et al A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma. Surgery 2002; 131:401–407. 
5. Yu W, Choi GS, Chung HY. Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer. Br J Surg 2006; 93:559–563. 
6. Toge T, Kameda A, Kuroi K, et al The role of the spleen in immunosuppression and the effects of splenectomy on prognosis in gastric cancer patients. Nippon Geka Gakkai Zasshi 1985; 86:1120–1123.
7. Yang K, Chen XZ, Hu JK, et al Effectiveness and safety of splenectomy for gastric carcinoma: a meta-analysis. World J Gastroenterol 2009; 15:5352–5359. 
8. Bonenkamp JJ, Songun I, Hermans J, et al Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995; 345:745–748. 25. 
9. Cuschieri A, Fayers P, Fielding J, et al Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet 1996; 347:995–999. 
10. Waddell T, Verheij M, Allum W, et al Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment, and follow-up. Ann Oncol 2013; 24:vi57–vi63. 
11. Sano T, Sasako M, Yamamoto S, et al Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy – Japan Clinical Oncology Group Study 9501. J Clin Oncol 2004; 22:2767–2773. 
12. Aoyagi K, Kouhuji K, Miyagi M, et al Prognosis of metastatic splenic hilum lymph node in patients with gastric cancer after total gastrectomy and splenectomy. World J Hepatol 2010; 2:81–86. 
13. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3).Gastric Cancer&